Ameditech Recalls
109 recalls on record · October 22, 2014 to October 7, 2020 · Medical Devices
Recalls by year
14
15
17
18
19
20
Count of recall notices naming this brand, by the year the recall was announced. A quiet year is not proof of a safe year.
December 30, 2015Medical DevicesFDA
Ameditech Inc recalls ProScreen Cup CLIA with 6 Panel Drug, Item No. PSCup-6MB-W
Hazard: Ameditechs Drugs of Abuse Tests listed above have shown reduced reactivity for up to two (2) of the nineteen (19) Benzodiazepine (BZO) compounds for which specificity information is provided in the product insert. The particular BZO compounds for which there may be reduced reactivity are Clonazepam and Chlordiazepoxide.
December 30, 2015Medical DevicesFDA
Ameditech Inc recalls ProScreen CLIA Wvd 12 Panel Cup w/Adult., Item No. PSCupA-12M-W
Hazard: Ameditechs Drugs of Abuse Tests listed above have shown reduced reactivity for up to two (2) of the nineteen (19) Benzodiazepine (BZO) compounds for which specificity information is provided in the product insert. The particular BZO compounds for which there may be reduced reactivity are Clonazepam and Chlordiazepoxide.
December 30, 2015Medical DevicesFDA
Ameditech Inc recalls ProScreen CLIA Waived Cup with 8 Drug, Item No. PSCup-8P-W
Hazard: Ameditechs Drugs of Abuse Tests listed above have shown reduced reactivity for up to two (2) of the nineteen (19) Benzodiazepine (BZO) compounds for which specificity information is provided in the product insert. The particular BZO compounds for which there may be reduced reactivity are Clonazepam and Chlordiazepoxide.
December 30, 2015Medical DevicesFDA
Ameditech Inc recalls ProScreen CLIA Waived Cup with 6 Drugs, Item No. PSCup-6BO-W
Hazard: Ameditechs Drugs of Abuse Tests listed above have shown reduced reactivity for up to two (2) of the nineteen (19) Benzodiazepine (BZO) compounds for which specificity information is provided in the product insert. The particular BZO compounds for which there may be reduced reactivity are Clonazepam and Chlordiazepoxide.
December 30, 2015Medical DevicesFDA
Ameditech Inc recalls ProScreen CLIA Waived Cup 6 Drugs w/Adul, Item No. PSCupA-6MB-W
Hazard: Ameditechs Drugs of Abuse Tests listed above have shown reduced reactivity for up to two (2) of the nineteen (19) Benzodiazepine (BZO) compounds for which specificity information is provided in the product insert. The particular BZO compounds for which there may be reduced reactivity are Clonazepam and Chlordiazepoxide.
December 30, 2015Medical DevicesFDA
Ameditech Inc recalls ProScreen 9 Panel Cup w/Adulterants, Item No. PSCUPA-9BO300
Hazard: Ameditechs Drugs of Abuse Tests listed above have shown reduced reactivity for up to two (2) of the nineteen (19) Benzodiazepine (BZO) compounds for which specificity information is provided in the product insert. The particular BZO compounds for which there may be reduced reactivity are Clonazepam and Chlordiazepoxide.
December 30, 2015Medical DevicesFDA
Ameditech Inc recalls ProScreen 8 Panel Dip Card w/Adult, Item No. PSDA-8P, PSDA-8MBO300
Hazard: Ameditechs Drugs of Abuse Tests listed above have shown reduced reactivity for up to two (2) of the nineteen (19) Benzodiazepine (BZO) compounds for which specificity information is provided in the product insert. The particular BZO compounds for which there may be reduced reactivity are Clonazepam and Chlordiazepoxide.
December 30, 2015Medical DevicesFDA
Ameditech Inc recalls ProScreen 8 Panel Dip Card w/Adult, Item No. PSDA-8P, PSDA-8MBO300
Hazard: Ameditechs Drugs of Abuse Tests listed above have shown reduced reactivity for up to two (2) of the nineteen (19) Benzodiazepine (BZO) compounds for which specificity information is provided in the product insert. The particular BZO compounds for which there may be reduced reactivity are Clonazepam and Chlordiazepoxide.
December 30, 2015Medical DevicesFDA
Ameditech Inc recalls ProScreen 8 Panel Dip Card, Item No. PSD-8P
Hazard: Ameditechs Drugs of Abuse Tests listed above have shown reduced reactivity for up to two (2) of the nineteen (19) Benzodiazepine (BZO) compounds for which specificity information is provided in the product insert. The particular BZO compounds for which there may be reduced reactivity are Clonazepam and Chlordiazepoxide.
December 30, 2015Medical DevicesFDA
Ameditech Inc recalls ProScreen 7 Panel Dip Card, Item No. PSD-7MPB, PSD-7MO, PSD-7M
Hazard: Ameditechs Drugs of Abuse Tests listed above have shown reduced reactivity for up to two (2) of the nineteen (19) Benzodiazepine (BZO) compounds for which specificity information is provided in the product insert. The particular BZO compounds for which there may be reduced reactivity are Clonazepam and Chlordiazepoxide.
December 30, 2015Medical DevicesFDA
Ameditech Inc recalls ProScreen 6 Panel Dip Drug Screen, Item No. PSD-6BUPO3
Hazard: Ameditechs Drugs of Abuse Tests listed above have shown reduced reactivity for up to two (2) of the nineteen (19) Benzodiazepine (BZO) compounds for which specificity information is provided in the product insert. The particular BZO compounds for which there may be reduced reactivity are Clonazepam and Chlordiazepoxide.
December 30, 2015Medical DevicesFDA
Ameditech Inc recalls ProScreen 6 Panel Dip Card w/Adult (AU), Item No. PSDA-6MBAU
Hazard: Ameditechs Drugs of Abuse Tests listed above have shown reduced reactivity for up to two (2) of the nineteen (19) Benzodiazepine (BZO) compounds for which specificity information is provided in the product insert. The particular BZO compounds for which there may be reduced reactivity are Clonazepam and Chlordiazepoxide.
December 30, 2015Medical DevicesFDA
Ameditech Inc recalls ProScreen 6 Panel Dip Card, Item No. PSCuPSD-6BUP300, PSD-6MTDBO300, PSD-6BUPO, PSD-6MBO, PSD-6MB,
Hazard: Ameditechs Drugs of Abuse Tests listed above have shown reduced reactivity for up to two (2) of the nineteen (19) Benzodiazepine (BZO) compounds for which specificity information is provided in the product insert. The particular BZO compounds for which there may be reduced reactivity are Clonazepam and Chlordiazepoxide.
December 30, 2015Medical DevicesFDA
Ameditech Inc recalls ProScreen 6 Panel Cup w/Adult (AU), Item No. PSCupA-6MBAU
Hazard: Ameditechs Drugs of Abuse Tests listed above have shown reduced reactivity for up to two (2) of the nineteen (19) Benzodiazepine (BZO) compounds for which specificity information is provided in the product insert. The particular BZO compounds for which there may be reduced reactivity are Clonazepam and Chlordiazepoxide.
December 30, 2015Medical DevicesFDA
Ameditech Inc recalls ProScreen 6 Panel Cassette w/Adult (AU), Item No. PSPA-6MBAU
Hazard: Ameditechs Drugs of Abuse Tests listed above have shown reduced reactivity for up to two (2) of the nineteen (19) Benzodiazepine (BZO) compounds for which specificity information is provided in the product insert. The particular BZO compounds for which there may be reduced reactivity are Clonazepam and Chlordiazepoxide.
December 30, 2015Medical DevicesFDA
Ameditech Inc recalls ProScreen 5 Panel Dip Card w/Adult, Item No. PSDA-5MB300
Hazard: Ameditechs Drugs of Abuse Tests listed above have shown reduced reactivity for up to two (2) of the nineteen (19) Benzodiazepine (BZO) compounds for which specificity information is provided in the product insert. The particular BZO compounds for which there may be reduced reactivity are Clonazepam and Chlordiazepoxide.
December 30, 2015Medical DevicesFDA
Ameditech Inc recalls ProScreen 5 Panel Dip Card, Item No. PSD-12BUP
Hazard: Ameditechs Drugs of Abuse Tests listed above have shown reduced reactivity for up to two (2) of the nineteen (19) Benzodiazepine (BZO) compounds for which specificity information is provided in the product insert. The particular BZO compounds for which there may be reduced reactivity are Clonazepam and Chlordiazepoxide.
December 30, 2015Medical DevicesFDA
Ameditech Inc recalls ProScreen 12 Panel Dip Card, Item No. PSD-12BUP
Hazard: Ameditechs Drugs of Abuse Tests listed above have shown reduced reactivity for up to two (2) of the nineteen (19) Benzodiazepine (BZO) compounds for which specificity information is provided in the product insert. The particular BZO compounds for which there may be reduced reactivity are Clonazepam and Chlordiazepoxide.
December 30, 2015Medical DevicesFDA
Ameditech Inc recalls ProScreen 12 Panel Cup w/Adult., Item No. PSCupA-12M
Hazard: Ameditechs Drugs of Abuse Tests listed above have shown reduced reactivity for up to two (2) of the nineteen (19) Benzodiazepine (BZO) compounds for which specificity information is provided in the product insert. The particular BZO compounds for which there may be reduced reactivity are Clonazepam and Chlordiazepoxide.
December 30, 2015Medical DevicesFDA
Ameditech Inc recalls ProScreen 12 Drug Cup w/Adulteration, Item No. PSCupA-12TBU
Hazard: Ameditechs Drugs of Abuse Tests listed above have shown reduced reactivity for up to two (2) of the nineteen (19) Benzodiazepine (BZO) compounds for which specificity information is provided in the product insert. The particular BZO compounds for which there may be reduced reactivity are Clonazepam and Chlordiazepoxide.
December 30, 2015Medical DevicesFDA
Ameditech Inc recalls ProScreen 10 Panel Dip Card w/Adult, Item No. PSDA-10MO, PSDA-10MMO300, PSDA-10PPX, PSDA-10BUP, PSD-12BUP, PSD-10M, PSC
Hazard: Ameditechs Drugs of Abuse Tests listed above have shown reduced reactivity for up to two (2) of the nineteen (19) Benzodiazepine (BZO) compounds for which specificity information is provided in the product insert. The particular BZO compounds for which there may be reduced reactivity are Clonazepam and Chlordiazepoxide.
December 30, 2015Medical DevicesFDA
Ameditech Inc recalls ProScreen 10 Panel Dip Card, Item No. PSD-10MOX, PSD-10MOB, PSD-10MMO300
Hazard: Ameditechs Drugs of Abuse Tests listed above have shown reduced reactivity for up to two (2) of the nineteen (19) Benzodiazepine (BZO) compounds for which specificity information is provided in the product insert. The particular BZO compounds for which there may be reduced reactivity are Clonazepam and Chlordiazepoxide.
December 30, 2015Medical DevicesFDA
Ameditech Inc recalls ProScProScreen 10 Panel Cup with Adulterants, Item No. PSCupA-10AM
Hazard: Ameditechs Drugs of Abuse Tests listed above have shown reduced reactivity for up to two (2) of the nineteen (19) Benzodiazepine (BZO) compounds for which specificity information is provided in the product insert. The particular BZO compounds for which there may be reduced reactivity are Clonazepam and Chlordiazepoxide.
December 30, 2015Medical DevicesFDA
Ameditech Inc recalls ProScreen 10 Panel Cup, Item No. PSCup-10M
Hazard: Ameditechs Drugs of Abuse Tests listed above have shown reduced reactivity for up to two (2) of the nineteen (19) Benzodiazepine (BZO) compounds for which specificity information is provided in the product insert. The particular BZO compounds for which there may be reduced reactivity are Clonazepam and Chlordiazepoxide.
December 30, 2015Medical DevicesFDA
Ameditech Inc recalls ProScreen 10 Drug Panel Cassette Test, Item No. PSP-10PPX
Hazard: Ameditechs Drugs of Abuse Tests listed above have shown reduced reactivity for up to two (2) of the nineteen (19) Benzodiazepine (BZO) compounds for which specificity information is provided in the product insert. The particular BZO compounds for which there may be reduced reactivity are Clonazepam and Chlordiazepoxide.
December 30, 2015Medical DevicesFDA
Ameditech Inc recalls Micro Screen 6 Panel Cup with Adult (AU), Item No. MSCA-6MBAU
Hazard: Ameditechs Drugs of Abuse Tests listed above have shown reduced reactivity for up to two (2) of the nineteen (19) Benzodiazepine (BZO) compounds for which specificity information is provided in the product insert. The particular BZO compounds for which there may be reduced reactivity are Clonazepam and Chlordiazepoxide.
December 30, 2015Medical DevicesFDA
Ameditech Inc recalls Immutest Cup CLIA Waived w/Adulteration, Item No. IMCA-7MT-W
Hazard: Ameditechs Drugs of Abuse Tests listed above have shown reduced reactivity for up to two (2) of the nineteen (19) Benzodiazepine (BZO) compounds for which specificity information is provided in the product insert. The particular BZO compounds for which there may be reduced reactivity are Clonazepam and Chlordiazepoxide.
December 30, 2015Medical DevicesFDA
Ameditech Inc recalls ImmuTest Cup 7-panel w/ Adulteration, Item No. IMCA-7P
Hazard: Ameditechs Drugs of Abuse Tests listed above have shown reduced reactivity for up to two (2) of the nineteen (19) Benzodiazepine (BZO) compounds for which specificity information is provided in the product insert. The particular BZO compounds for which there may be reduced reactivity are Clonazepam and Chlordiazepoxide.
December 30, 2015Medical DevicesFDA
Ameditech Inc recalls ImmuTest 12 Panel Dip Card, Item No. IMD-12MO3
Hazard: Ameditechs Drugs of Abuse Tests listed above have shown reduced reactivity for up to two (2) of the nineteen (19) Benzodiazepine (BZO) compounds for which specificity information is provided in the product insert. The particular BZO compounds for which there may be reduced reactivity are Clonazepam and Chlordiazepoxide.
December 30, 2015Medical DevicesFDA
Ameditech Inc recalls Immutest 12 Panel Cup w/Adulteration, Item No. IMCA-11OP
Hazard: Ameditechs Drugs of Abuse Tests listed above have shown reduced reactivity for up to two (2) of the nineteen (19) Benzodiazepine (BZO) compounds for which specificity information is provided in the product insert. The particular BZO compounds for which there may be reduced reactivity are Clonazepam and Chlordiazepoxide.